⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research
prnewswire.com
MRK
PFE
BMY
JNJ
AZN
CGON
ASRT
Global Protein Expression Market to Reach USD 7.30 Billion by 2034 at 8.8% CAGR as Rising Biopharmaceutical Development, Growing Demand for Recombinant Proteins, and Advances in Cell-Free Expression Technologies Accelerate Market Growth, Reports Maximize
prnewswire.com
TMO
AMGN
AGNC
BIO
QGEN
BIIB
GILD
REGN
BMY
MRK
SNY
LLY
ABBV
PFE
JNJ
AZN
BSX
MDLZ
GEHC
SYK
EW
ISRG
GOOG
MSFT
NVDA
AMAT
KLAC
LRCX
INTC
AMD
MU
WDC
SE
CRM
IBM
ORCL
SAP
ACN
GEN
PRG
EXAS
DXCM
ALGN
IDXX
VRTX
XRAY
CTAS
MDT
AMZN
GOOGL
CTSH
INFY
HPE
DELL
HPQ
LOGI
ADBE
CDNS
SNPS
MRVL
QCOM
NXPI
ON
ADI
TXN
MCHP
QRVO
NTAP
STX
WD
CRWD
PANW
FTNT
DDOG
SNOW
ETSY
ROKU
PYPL
MELI
JD
BABA
NTES
PDD
IQ
VIPS
NIO
LI
XPEV
RIVN
TSLA
GM
F
STLA
TM
VWAGY
HOG
La NHHF pone en marcha el «NHHF Action Fund» mientras cientos de líderes del sector sanitario se reúnen en Washington
prnewswire.com
UNH
PFE
CNC
JNJ
NHHF Launches NHHF Action Fund as Hundreds of Health Leaders Gather in Washington
prnewswire.com
UNH
PFE
CNC
JNJ
Surgical Devices Market Size to Worth USD 27.14 Billion by 2030, at a CAGR of 14.7% – MarketsandMarkets™
globenewswire.com
JNJ
ISRG
SYK
BSX
CNMD
New model-based analysis further supports the potential of TECVAYLI®▼ (teclistamab) plus daratumumab to redefine long-term survival expectations in early line relapsed/refractory multiple myeloma
globenewswire.com
JNJ
New model-based analysis further supports the potential of TECVAYLI® (teclistamab-cqyv) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) to redefine long-term survival expectations in early line relapsed/refractory multiple myeloma
prnewswire.com
JNJ
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now
globenewswire.com
JNJ
MD
STX
ZBH
ISRG
eClinical Solutions Market by Product, Application, Trial Phase, End User, Regulatory, AI, Growth, Market Size - Forecast to 2030
globenewswire.com
PFE
JNJ
VEEV
IQV
ICLR
ORCL
Stress Urinary Incontinence Devices Market Poised for Growth Through 2034, Driven by Innovation, Rising Awareness and Expanding Treatment Opportunities
globenewswire.com
BSX
JNJ
CMT